AEterna Zentaris (AEZS) Sells Echelon Biosciences Inc. to Frontier Scientific Inc.
12/3/2007 7:11:01 AM
More...
|
Lpath, Inc. and Echelon Biosciences Inc. Introduce New Cancer Research Assay Based on Lpath's Breakthrough Anti-Cancer Drug Candidate, Sphingomab(TM)
7/10/2007 10:16:30 AM
More...
|
Echelon Biosciences Inc. Granted US Patent For PI3K Reinforcing Its Leadership In The Commercialization Of Cancer Assays
6/19/2006 12:32:12 PM
More...
|
Lumiphore Inc. And Echelon Biosciences Inc. Introduce Novel Cancer Assays
4/4/2006 10:55:01 AM
More...
|
ComGenex Inc. Transfers To Echelon Biosciences Inc. Jointly Developed Intellectual Property For Cancer Compounds
10/19/2005 5:12:36 PM
More...
|
AEterna Zentaris (AEZS) Strengthens Its Position In The Development Of Innovative Signal Transduction Inhibitors As A Potential Way To Treat Cancer
10/19/2005 5:11:56 PM
More...
|
ComGenex Inc. And Echelon Biosciences Inc. Expand Their Drug Discovery Collaboration
10/19/2005 5:11:55 PM
More...
|
Echelon Biosciences Inc. Inc. Joins Forces With An M. D. Anderson Cancer Center Researcher To Advance The Fight Against Cancer
10/19/2005 5:10:56 PM
More...
|